Premium
Alteration of Cytokine Production in Follicular Cystic Ovaries Induced in Mice by Neonatal Estradiol Injection
Author(s) -
DESHPANDE ROHINI R.,
CHAPMAN JOHN C.,
MICHAEL SANDRA D.,
DESHPANDE ROHINI R.,
CHANG MINGDER Y.
Publication year - 2000
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/j.8755-8920.2000.440203.x
Subject(s) - medicine , cytokine , endocrinology , aromatase , estrogen , follicular phase , tumor necrosis factor alpha , biology , cancer , breast cancer
PROBLEM: Neonatal estradiol injections in mice lead to follicular cystic ovaries that are similar to ovaries in patients with polycystic ovarian syndrome (PCOS). The present study examined ovarian cytokine production following neonatal estradiol injection.
METHOD OF STUDY: Female (C3H/HeJ×129/HeJ)F 1 mice were injected daily with 20 μg 17β‐estradiol from 0–3 days postpartum. At intervals, animals were sacrificed to determine ovarian architecture, circulating levels of estradiol, ovarian and peritoneal machrophage cytokine production, and ovarian P450 aromatase enzyme mRNA levels.
RESULTS: Similar to PCOS, our results show that neonatally estradiol‐injected mice have lower levels of circulating estrogen that are correlated with decreased mRNA levels of P450 aromatase enzyme. Our data also show that follicular cystic ovaries have increased tumor necrosis factor (TNF)‐α and interleukin (IL)‐6 production. This increase in TNF‐α and IL‐6 production is also observed in peritoneal macrophages of estradiol‐injected mice.
CONCLUSION: The present study showed that neonatal estrogen injection in mice has an overall systemic effect on cytokine production. We speculate that increased cytokine production may alter certain important steps in follicular maturation, ultimately contributing to ovarian dysfunction.